175 related articles for article (PubMed ID: 29961683)
1. Hospitalization Increases the Risk of Acute Arthritic Flares in Gout: A Population-based Study over 2 Decades.
Zleik N; Elfishawi MM; Kvrgic Z; Michet CJ; Crowson CS; Matteson EL; Bongartz T
J Rheumatol; 2018 Aug; 45(8):1188-1191. PubMed ID: 29961683
[TBL] [Abstract][Full Text] [Related]
2. Changes in the Presentation of Incident Gout and the Risk of Subsequent Flares: A Population-based Study over 20 Years.
Elfishawi MM; Zleik N; Kvrgic Z; Michet CJ; Crowson CS; Matteson EL; Bongartz T
J Rheumatol; 2020 Apr; 47(4):613-618. PubMed ID: 31308206
[TBL] [Abstract][Full Text] [Related]
3. Validation of claims-based algorithms for gout flares.
MacFarlane LA; Liu CC; Solomon DH; Kim SC
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):820-6. PubMed ID: 27230083
[TBL] [Abstract][Full Text] [Related]
4. Frequency and risk factors of gout flares in a large population-based cohort of incident gout.
Rothenbacher D; Primatesta P; Ferreira A; Cea-Soriano L; Rodríguez LA
Rheumatology (Oxford); 2011 May; 50(5):973-81. PubMed ID: 21228059
[TBL] [Abstract][Full Text] [Related]
5. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
[TBL] [Abstract][Full Text] [Related]
6. The effect of serum urate on gout flares and their associated costs: an administrative claims analysis.
Halpern R; Fuldeore MJ; Mody RR; Patel PA; Mikuls TR
J Clin Rheumatol; 2009 Feb; 15(1):3-7. PubMed ID: 19125135
[TBL] [Abstract][Full Text] [Related]
7. Definition of hyperuricemia and gouty conditions.
Bardin T; Richette P
Curr Opin Rheumatol; 2014 Mar; 26(2):186-91. PubMed ID: 24419750
[TBL] [Abstract][Full Text] [Related]
8. The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden.
Kapetanovic MC; Nilsson P; Turesson C; Englund M; Dalbeth N; Jacobsson L
Arthritis Res Ther; 2018 Aug; 20(1):190. PubMed ID: 30157929
[TBL] [Abstract][Full Text] [Related]
9. Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis.
Jackson R; Shiozawa A; Buysman EK; Altan A; Korrer S; Choi H
BMJ Open; 2015 Jun; 5(6):e007214. PubMed ID: 26109113
[TBL] [Abstract][Full Text] [Related]
10. Hyperuricemia and gout: new concepts in diagnosis and management.
Doghramji PP; Wortmann RL
Postgrad Med; 2012 Nov; 124(6):98-109. PubMed ID: 23322143
[TBL] [Abstract][Full Text] [Related]
11. Physical Function, Hyperuricemia, and Gout in Older Adults.
Burke BT; Köttgen A; Law A; Windham BG; Segev D; Baer AN; Coresh J; McAdams-DeMarco MA
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1730-8. PubMed ID: 26138016
[TBL] [Abstract][Full Text] [Related]
12. Risk of gout flare after medication: prescription symmetry sequence analysis.
Lai SW; Hwang BF; Kuo YH; Liu CS; Liao KF
Clin Rheumatol; 2024 Mar; 43(3):1183-1188. PubMed ID: 38305936
[TBL] [Abstract][Full Text] [Related]
13. Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial.
Schumacher HR; Sundy JS; Terkeltaub R; Knapp HR; Mellis SJ; Stahl N; Yancopoulos GD; Soo Y; King-Davis S; Weinstein SP; Radin AR;
Arthritis Rheum; 2012 Mar; 64(3):876-84. PubMed ID: 22223180
[TBL] [Abstract][Full Text] [Related]
14. Which factors predict discordance between a patient and physician on a gout flare?
Jagpal A; Rahn EJ; Mudano AS; Dalbeth N; Taylor W; Saag KG; Singh JA; Cavagna L; Uhlig T; Perez-Ruiz F; McCarthy G; Gerritsen M; Stamp L; Vazquez Mellado J; Lin C; Vargas-Santos AB; Louthrenoo W; Neogi T; Chen YH; Castelar-Pinheiro GDR; Gaffo A
Rheumatology (Oxford); 2021 Feb; 60(2):773-779. PubMed ID: 32793971
[TBL] [Abstract][Full Text] [Related]
15. Contemporary epidemiology of gout and hyperuricemia in community elderly in Beijing.
Lu X; Li X; Zhao Y; Zheng Z; Guan S; Chan P
Int J Rheum Dis; 2014 May; 17(4):400-7. PubMed ID: 24118986
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of gout.
Grassi W; De Angelis R
Reumatismo; 2012 Jan; 63(4):238-45. PubMed ID: 22303530
[TBL] [Abstract][Full Text] [Related]
17. Sleep Apnea and the Risk of Incident Gout: A Population-Based, Body Mass Index-Matched Cohort Study.
Zhang Y; Peloquin CE; Dubreuil M; Roddy E; Lu N; Neogi T; Choi HK
Arthritis Rheumatol; 2015 Dec; 67(12):3298-302. PubMed ID: 26477891
[TBL] [Abstract][Full Text] [Related]
18. Management of Gout and Hyperuricemia in CKD.
Vargas-Santos AB; Neogi T
Am J Kidney Dis; 2017 Sep; 70(3):422-439. PubMed ID: 28456346
[TBL] [Abstract][Full Text] [Related]
19. Onset of comorbidities and flare patterns within pre-existing morbidity clusters in people with gout: 5-year primary care cohort study.
Bajpai R; Muller S; Mallen C; Watson L; Richette P; Hider SL; Roddy E
Rheumatology (Oxford); 2021 Dec; 61(1):407-412. PubMed ID: 33744931
[TBL] [Abstract][Full Text] [Related]
20. Serum uric acid levels and the risk of flares among gout patients in a US managed care setting.
Shiozawa A; Buysman EK; Korrer S
Curr Med Res Opin; 2017 Jan; 33(1):117-124. PubMed ID: 27659103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]